Dermata Therapeutics, Inc. (DRMA)
1.21
-0.02
(-1.63%)
USD |
NASDAQ |
Sep 04, 16:00
1.24
+0.03
(+2.48%)
After-Hours: 20:00
Dermata Therapeutics Total Liabilities (Quarterly) : 1.833M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.833M |
| March 31, 2026 | 1.053M |
| December 31, 2025 | 1.640M |
| September 30, 2025 | 1.111M |
| June 30, 2025 | 1.026M |
| March 31, 2025 | 2.704M |
| December 31, 2024 | 1.973M |
| September 30, 2024 | 1.946M |
| June 30, 2024 | 1.918M |
| March 31, 2024 | 1.372M |
| December 31, 2023 | 1.624M |
| Date | Value |
|---|---|
| September 30, 2023 | 0.9168M |
| June 30, 2023 | 0.6829M |
| March 31, 2023 | 1.207M |
| December 31, 2022 | 0.9226M |
| September 30, 2022 | 1.504M |
| June 30, 2022 | 1.366M |
| March 31, 2022 | 1.192M |
| December 31, 2021 | 1.517M |
| September 30, 2021 | 1.195M |
| June 30, 2021 | 1.643M |
| March 31, 2021 | 0.9392M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 46.19M |
| Perspective Therapeutics, Inc. | 68.16M |
| MiMedx Group, Inc. | 65.00M |
| ABVC BioPharma, Inc. | 7.131M |
| Endonovo Therapeutics, Inc. | 30.09M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.321M |
| Shareholders Equity (Quarterly) | 3.488M |
| Current Ratio | 2.803 |